2CELH : Celsius Holdings's Options Frenzy: What You Need to Know
Options trading presents higher risks and potential rewards. Astute traders manage these risks by continually educating ...
Biomednewsbreaks - Calidi Biotherapeutics Inc. (NYSE American: CLDI) Announces $3.9 Million Registered Direct Offering And Private Placement
Calidi Biotherapeutics (NYSE American: CLDI) , a clinical-stage biotechnology company advancing targeted immunotherapies, has entered into a securiti ...
Harrow, Inc. (HROW) Q4 2024 Earnings Conference Call
Q4 2024 - Earnings Conference Call March 28, 2025 8:00 AM ET. Company Participants. Jamie Webb - Director, Communications & IR Mark Baum - CEO Andrew Bo ...
Calidi Biotherapeutics Announces Pricing of $3.9 Million Registered Direct Offering and Concurrent Private Placement
Calidi Biotherapeutics, Inc. (NYSE AMERICAN: CLDI) (“Calidi” or the “Company”), a clinical-stage biotechnology company developing a new generation of targeted immunotherapies, today announced that it ...
Calidi prices 3.33M shares at 65c in registered direct offering
Biotherapeutics has entered into a definitive securities purchase agreement with a single institutional investor for the purchase ...
Q4 2024 Corvus Pharmaceuticals Inc Earnings Call
Thank you for standing by and welcome to the Corvus Pharmaceuticals fourth-quarter and full-year 2024 business update and financial results conference call. (Operator Instructions) It is now my ...
Corvus Pharmaceuticals outlines clinical milestones for soquelitinib in 2025
Discover Corvus Pharmaceuticals' Q4 2024 earnings insights, highlighting soquelitinib's trial progress, upcoming milestones for 2025, and robust ...
MicroVision's Strategic Moves And New CTO Drive Analyst Confidence, But Challenges Remain In Q4
D. Boral Capital analyst Jesse Sobelson reiterated a Buy rating on the shares of MicroVision Inc (NASDAQ:MVIS) with a price ...